Khan, K. http://orcid.org/0000-0003-3836-2827
Hall, C. L.
Babbage, C.
Dodzo, S.
Greenhalgh, C.
Lucassen, M.
Merry, S.
Sayal, K.
Sprange, K.
Stasiak, K.
Tench, C. R.
Townsend, E.
Stallard, P.
Hollis, C.
,
Article History
Received: 17 July 2023
Accepted: 12 March 2024
First Online: 26 March 2024
Declarations
:
: The SPARX-UK trial obtained ethical approval from the South West-Cornwall & Plymouth Research Ethics Committee on 15 December 2022 (Ethics Ref.: 22/SW/0149).
: Not applicable
: The intellectual property for SPARX is held by UniServices at the University of Auckland. Any proceeds from licensing or selling SPARX outside of New Zealand will be shared in part with UniServices and Sally Merry, Karolina Stasiak, Mathijs Lucassen, and two other co-developers (not involved in the current study). Kapil Sayal was an Expert Panel Member for the NICE Depression in Children and Young People Guideline Update Committee (CG28). The other authors declare that they have no competing interests.